Cargando…

Platelet-expressed immune checkpoint regulator GITRL in breast cancer

Owing to their key role in several diseases including cancer, activating and inhibitory immune checkpoint molecules are increasingly exploited as targets for immunotherapy. Recently, we demonstrated that platelets, which largely influence tumor progression and immune evasion, functionally express th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yanjun, Heitmann, Jonas S., Clar, Kim L., Kropp, Korbinian N., Hinterleitner, Martina, Engler, Tobias, Koch, André, Hartkopf, Andreas D., Zender, Lars, Salih, Helmut R., Maurer, Stefanie, Hinterleitner, Clemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360840/ https://www.ncbi.nlm.nih.gov/pubmed/33538861 http://dx.doi.org/10.1007/s00262-021-02866-y

Ejemplares similares

Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression
por: Rittig, Susanne M., et al.
Publicado: (2022)

Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
por: Hinterleitner, Clemens, et al.
Publicado: (2021)

Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
por: Zhou, Yanjun, et al.
Publicado: (2021)

Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
por: Clar, Kim L., et al.
Publicado: (2019)

Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
por: Lutz, Martina Svenja, et al.
Publicado: (2022)

Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies
por: Hinterleitner, Martina, et al.
Publicado: (2021)

Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
por: Sirgiovanni, Mattia, et al.
Publicado: (2021)

Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
por: Hinterleitner, Clemens, et al.
Publicado: (2021)

Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients
por: Schmidt, Moritz, et al.
Publicado: (2022)

Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance—A Retrospective, Long-Term Single-Center Experience
por: Schmidt, Moritz, et al.
Publicado: (2023)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
por: Hagelstein, Ilona, et al.
Publicado: (2021)

DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
por: Chashchina, Anna, et al.
Publicado: (2021)

NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma
por: Schmidt, Moritz, et al.
Publicado: (2023)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Modulation of Immune Responses by Platelet-Derived ADAM10
por: Maurer, Stefanie, et al.
Publicado: (2020)

Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report
por: Stingu, Elena, et al.
Publicado: (2023)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro
por: Kauer, Joseph, et al.
Publicado: (2022)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
por: Kaban, Kübra, et al.
Publicado: (2021)

NUT Carcinoma—An Underdiagnosed Malignancy
por: Lauer, Ulrich M., et al.
Publicado: (2022)

Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer
por: Kaban, Kübra, et al.
Publicado: (2021)

Long-term prognostic factors for PRRT in neuroendocrine tumors
por: Trautwein, Nils Florian, et al.
Publicado: (2023)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation
por: Hinterleitner, Martina, et al.
Publicado: (2022)

The Role of GITR/GITRL Interaction in Autoimmune Diseases
por: Tian, Jie, et al.
Publicado: (2020)

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
por: Hagelstein, Ilona, et al.
Publicado: (2022)

Quality of synthetic speech: perceptual dimensions, influencing factors, and instrumental assessment
por: Hinterleitner, Florian
Publicado: (2017)

GITR-GITRL System, A Novel Player in Shock and Inflammation
por: Krausz, Ludovic Tibor, et al.
Publicado: (2007)

Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol
por: Werner, Sebastian, et al.
Publicado: (2020)

Party Politics vs. Grievance Politics: Competing Modes of Representative Democracy
por: Flinders, Matthew, et al.
Publicado: (2022)

Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia
por: Marconato, Maddalena, et al.
Publicado: (2022)

Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy
por: Ekert, Kaspar, et al.
Publicado: (2020)

Th17/Treg Cells Imbalance and GITRL Profile in Patients with Hashimoto’s Thyroiditis
por: Liu, Yingzhao, et al.
Publicado: (2014)

A Stochastic Version of the Jansen and Rit Neural Mass Model: Analysis and Numerics
por: Ableidinger, Markus, et al.
Publicado: (2017)

Structures of mouse and human GITR–GITRL complexes reveal unique TNF superfamily interactions
por: Wang, Feng, et al.
Publicado: (2021)

Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma
por: Chan, Meilin, et al.
Publicado: (2021)

Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course
por: Clar, Kim L., et al.
Publicado: (2021)

Correlation of Increased Blood Levels of GITR and GITRL with Disease Severity in Patients with Primary Sjögren's Syndrome
por: Gan, Xiaoxia, et al.
Publicado: (2013)

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment
por: Pedroza-Gonzalez, Alexander, et al.
Publicado: (2013)

A Comparison of Different Counting Methods for a Holographic Particle Counter: Designs, Validations and Results
por: Brunnhofer, Georg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cc09q84k93qo01u7c2bf63amiq